Skip to main content

“DNA-based NANOdevices for the point-of-care electrochemical detection of AntiBodies”

Project description

DNA-based antibody detection platforms to facilitate diagnosis

Antibody detection plays an indispensable role in the diagnosis of many health conditions, including infectious, autoimmune and oncological diseases. The EU-funded DNA-NANO-AB project is proposing the development of DNA-based, rapid, user-friendly, sensitive and low-cost electrochemical nanodevices for the detection of clinically relevant antibodies that could be introduced as point-of-care applications. The project will achieve this through the rational design and fabrication of disposable DNA-based sensor platforms, where the detection of specific antibodies will be amplified via an electrochemical read-out approach. The developed platforms will be characterised, optimised and tested using immunoglobulin levels in real representative samples.

Coordinator

UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA
Net EU contribution
€ 251 002,56
Address
Via Cracovia 50
00133 Roma
Italy

See on map

Region
Centro (IT) Lazio Roma
Activity type
Higher or Secondary Education Establishments
Other funding
€ 0,00

Partners (1)

Partner

Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
United States
Net EU contribution
€ 0,00
Address
Franklin Street 1111 12 Floor
94607 Oakland Ca

See on map

Activity type
Higher or Secondary Education Establishments
Other funding
€ 165 265,92